Difficulty: Medium
Average Score: 72%
Practice
A 74-year-old man with bladder cancer and refractory depression is tried on a new agent to help his depression. Tranylcypromine is begun by his primary care physician. Which of the following adverse reactions may be expected in this patient?
Correct answer
A
Rationale
The correct answer is A) Anxiety. Tranylcypromine is a monoamine oxidase inhibitor (MAOI) used to treat depression. MAOIs can lead to an increase in anxiety due to their mechanism of action on neurotransmitters like serotonin and norepinephrine. The inhibition of MAO can cause these neurotransmitters to accumulate, leading to increased stimulation which may manifest as anxiety in some patients.
Option B) Hepatitis is incorrect because tranylcypromine is not known to cause liver toxicity or hepatitis as a common adverse reaction.
Option C) Normalization of blood glucose levels is incorrect because tranylcypromine does not have a direct effect on blood glucose levels.
Option D) Salivation is incorrect because tranylcypromine is not associated with changes in salivation as an adverse reaction.
In an educational context, understanding the potential adverse reactions of pharmacological treatments is crucial for healthcare providers to make informed decisions and provide safe care to patients. Knowing the expected side effects of medications allows for early recognition and management of adverse reactions, improving patient outcomes and safety. It also highlights the importance of thorough assessment, monitoring, and patient education when initiating new pharmacological treatments, especially in vulnerable populations like older adults with multiple comorbidities.
Option B) Hepatitis is incorrect because tranylcypromine is not known to cause liver toxicity or hepatitis as a common adverse reaction.
Option C) Normalization of blood glucose levels is incorrect because tranylcypromine does not have a direct effect on blood glucose levels.
Option D) Salivation is incorrect because tranylcypromine is not associated with changes in salivation as an adverse reaction.
In an educational context, understanding the potential adverse reactions of pharmacological treatments is crucial for healthcare providers to make informed decisions and provide safe care to patients. Knowing the expected side effects of medications allows for early recognition and management of adverse reactions, improving patient outcomes and safety. It also highlights the importance of thorough assessment, monitoring, and patient education when initiating new pharmacological treatments, especially in vulnerable populations like older adults with multiple comorbidities.